A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

New Technique for Distinguishing between Human Chromosomes

Sumner, A. T., Evans, H. J., & Buckland, R. A. (1971) · Nature New Biology · doi:10.1038/newbio232031a0 · Cited by 1,166 · see citing works

Technique for Identifying Y Chromosomes in Human Interphase Nuclei

Pearson, P. L., Bobrow, M., & Vosa, C. G. (1970) · Nature · doi:10.1038/226078a0 · Cited by 455 · see citing works

DNA Contents of Chromosome Ph 1 and Chromosome 21 in Human Chronic Granulocytic Leukemia

Rudkin, G. T., Hungerford, D. A., & Nowell̀, P. C. (1964) · Science · doi:10.1126/science.144.3623.1229 · Cited by 199 · see citing works

Clinical Implications of Cytogenetic Variants in Chronic Myelocytic Leukemia (CML)

Whang‐Peng, J., Canellos, G. P., Carbone, P. P., & TJIO, J. H. (1968) · Blood · doi:10.1182/blood.v32.5.755.755 · Cited by 179 · see citing works

Philadelphia-Chromosome-Positive and -Negative Chronic Myelocytic Leukemia

Ezdinli, E. Z., SOKAL, J. E., CROSSWHITE, L., & SANDBERG, A. A. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-2-175 · Cited by 177 · see citing works

Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis

Caspersson, T. O., Gahrton, G., Lindsten, J., & Zech, L. (1970) · Experimental Cell Research · doi:10.1016/0014-4827(70)90362-9 · Cited by 172 · see citing works

Chromosome Studies in Preleukemia

Rowley, J. D., Blaisdell, R. K., Jacobson, L., Mikuta, J. C., Byrne, R., & Shepley, L. A. (1966) · Blood · doi:10.1182/blood.v27.6.782.782 · Cited by 132 · see citing works

Distinguishing between the Chromosomes involved in Down's Syndrome (Trisomy 21) and Chronic Myeloid Leukaemia (Ph1) by Fluorescence

O'Riordan, M. L., Robinson, J. A., BUCKTON, K. E., & Evans, H. J. (1971) · Nature · doi:10.1038/230167a0 · Cited by 129 · see citing works

Identification by fluorescence of the G chromosome lost in human meningomas

Mark, J., Levan, G., & Mitelman, F. (2009) · Hereditas · doi:10.1111/j.1601-5223.1972.tb01017.x · Cited by 115 · see citing works

IDENTIFICATION OF ISOCHROMOSOME 17 IN MYELOID LEUKÆMIA

Lobb, D., Reeves, B. R., & Lawler, S. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90836-7 · Cited by 48 · see citing works

Relationship of Centromeric Heterochromatin to Fluorescent Banding Patterns of Metaphase Chromosomes in the Mouse

Rowley, J. D., & Bodmer, W. F. (1971) · Nature · doi:10.1038/231503a0 · Cited by 46 · see citing works

Identification of G-group chromosomes by fluorescence staining

Mikkelsen, M., & Niebuhr, E. (1971) · Cited by 28 · see citing works

Reuse of chromosome preparations for fluorescent staining.

Rowley, J. D., Potter, D., & Mikuta, J. C. (1971) · PubMed · Cited by 11 · see citing works

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H. M., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,237 · see citing works

Recurrent Fusion of <i>TMPRSS2</i> and ETS Transcription Factor Genes in Prostate Cancer

Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846 · see citing works

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,618 · see citing works

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

O’Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T. H., Hochhaus, A., Hughes, T. P., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,550 · see citing works

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Druker, B. J., Guilhot, F., O’Brien, S. G., Gathmann, I., Kantarjian, H. M., Gattermann, N., Deininger, M. W., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,473 · see citing works

The cancer genome

Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,458 · see citing works

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

Lozzio, C., & Lozzio, B. (1975) · Blood · doi:10.1182/blood.v45.3.321.bloodjournal453321 · Cited by 2,978 · see citing works

Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome

Daley, G. Q., Etten, R. A. V., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 2,141 · see citing works

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

Kantarjian, H., Sawyers, C. L., Hochhaus, A., Guilhot, F., Schiffer, C. A., Gambacorti-Passerini, C. B., Niederwieser, D. W., Resta, D. J., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,005 · see citing works

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

Dalla‐Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,764 · see citing works

The molecular biology of chronic myeloid leukemia

Deininger, M. W., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,654 · see citing works

Chronic Myeloid Leukemia

Sawyers, C. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401706 · Cited by 1,615 · see citing works

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,583 · see citing works

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

Groffen, J., Stephenson, J. R., Heisterkamp, N., DeKlein, A., Bartram, C., & Grosveld, G. C. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,578 · see citing works

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · see citing works

The impact of translocations and gene fusions on cancer causation

Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400 · see citing works

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

Capdeville, R., Buchdunger, E., Zimmermann, J., & Matter, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd839 · Cited by 1,391 · see citing works

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R. (1982) · Nature · doi:10.1038/300765a0 · Cited by 1,378 · see citing works

The Biology of Chronic Myeloid Leukemia

Faderl, S. H., Talpaz, M., Estrov, Z. E., O'Brien, S. M., Kurzrock, R., & Kantarjian, H. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410306 · Cited by 1,296 · see citing works

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

Deininger, M. W., Buchdunger, E., & Druker, B. J. (2004) · Blood · doi:10.1182/blood-2004-08-3097 · Cited by 1,252 · see citing works

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

Cleary, M. L., Smith, S. D., & Sklar, J. (1986) · Cell · doi:10.1016/0092-8674(86)90362-4 · Cited by 1,212 · see citing works

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

Graham, S. M., Jørgensen, H. G., Allan, E., Pearson, C., Alcorn, M. J., Richmond, L., & Holyoake, T. L. (2002) · Blood · doi:10.1182/blood.v99.1.319 · Cited by 1,174 · see citing works

Clonal hematopoiesis in human aging and disease

Jaiswal, S., & Ebert, B. L. (2019) · Science · doi:10.1126/science.aan4673 · Cited by 1,156 · see citing works

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

Sawyers, C. L. (2002) · Blood · doi:10.1182/blood.v99.10.3530 · Cited by 1,139 · see citing works

Two genetic hits (more or less) to cancer

Knudson, A. G. (2001) · Nature reviews. Cancer · doi:10.1038/35101031 · Cited by 1,122 · see citing works

The Chromosomal Basis of Human Neoplasia

Yunis, J. J. (1983) · Science · doi:10.1126/science.6336310 · Cited by 1,079 · see citing works

Acute lymphoblastic leukaemia

Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074 · see citing works

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

Talpaz, M. (2002) · Blood · doi:10.1182/blood.v99.6.1928 · Cited by 1,011 · see citing works

Stem cell concepts renew cancer research.

Dick, J. (2008) · Blood · doi:10.1182/blood-2008-08-077941 · Cited by 1,126 · see citing works

Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

Goldman, J. M., & Melo, J. V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020777 · Cited by 946 · see citing works

Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes

Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.021 · Cited by 886 · see citing works

Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Druker, B. J., & Lydon, N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9083 · Cited by 881 · see citing works

Structural organization of the bcr gene and its role in the Ph′ translocation

Heisterkamp, N., Stam, K., Groffen, J., de Klein, A., & Grosveld, G. C. (1985) · Nature · doi:10.1038/315758a0 · Cited by 874 · see citing works

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity

Konopka, J. B., Watanabe, S. M., & Witte, O. N. (1984) · Cell · doi:10.1016/0092-8674(84)90438-0 · Cited by 872 · see citing works

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

Fialkow, P. J., Jacobson, R. J., & Papayannopoulou, T. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90124-3 · Cited by 851 · see citing works

Characteristic chromosomal abnormalities in biopsies and lymphoid‐cell lines from patients with burkitt and non‐burkitt lymphomas

Zech, L., Haglund, U., Nilsson, K., & Klein, G. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170108 · Cited by 848 · see citing works

Imatinib Mesylate — A New Oral Targeted Therapy

Savage, D. G., & Antman, K. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmra013339 · Cited by 841 · see citing works

The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias

Epstein, F. H., Kurzrock, R., Gutterman, J. U., & Talpaz, M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191506 · Cited by 833 · see citing works

Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia

Heisterkamp, N., Stephenson, J. R., Groffen, J., Hansen, P. F., de Klein, A., Bartram, C. R., & Grosveld, G. C. (1983) · Nature · doi:10.1038/306239a0 · Cited by 833 · see citing works

TopHat-Fusion: an algorithm for discovery of novel fusion transcripts

Kim, D., & Salzberg, S. L. (2011) · Genome biology · doi:10.1186/gb-2011-12-8-r72 · Cited by 806 · see citing works

The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene

Ben‐Neriah, Y., Daley, G. Q., Mes‐Masson, A., Witte, O. N., & Baltimore, D. (1986) · Science · doi:10.1126/science.3460176 · Cited by 797 · see citing works

PAX8-PPAR γ 1 Fusion in Oncogene Human Thyroid Carcinoma

Kroll, T. G., Sarraf, P., Pecciarini, L., Chen, C., Mueller, E., Spiegelman, B. M., & Fletcher, J. A. (2000) · Science · doi:10.1126/science.289.5483.1357 · Cited by 780 · see citing works

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance

Mahon, F., Deininger, M. W., Schultheis, B. S., Chabrol, J., Reiffers, J. J., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.3.1070 · Cited by 776 · see citing works

Apoptosis and cancer: the genesis of a research field

Cotter, T. G. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2663 · Cited by 761 · see citing works

Identification of Targetable FGFR Gene Fusions in Diverse Cancers

Wu, Y.-M., Su, F., Sundaram, S. K., Khazanov, N. A., Ateeq, B., Cao, X., Lonigro, R. J., Vats, P., Wang, R., Lin, S., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0050 · Cited by 748 · see citing works

The colorectal adenoma–carcinoma sequence

Leslie, A., CAREY, F. A., Pratt, N. R., & Steele, R. J. (2002) · British journal of surgery · doi:10.1046/j.1365-2168.2002.02120.x · Cited by 743 · see citing works

Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia

Bartram, C. R., de Klein, A., Hagemeijer, A., van Agthoven, T., van Kessel, A. G., Bootsma, D., Grosveld, G. C., Ferguson-Smith, M. A., Davies, T., Stone, M., et al. (1983) · Nature · doi:10.1038/306277a0 · Cited by 738 · see citing works

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

Kawasaki, E. S., Clark, S., Coyne, M. Y., Smith, S. D., Champlin, R. E., Witte, O. N., & McCormick, F. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5698 · Cited by 701 · see citing works

The emerging complexity of gene fusions in cancer

Mertens, F., Johansson, B., Fioretos, T., & Mitelman, F. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3947 · Cited by 675 · see citing works

The secret ally: immunostimulation by anticancer drugs

Galluzzi, L., Senovilla, L., Zitvogel, L., & Kroemer, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3626 · Cited by 670 · see citing works

Translation of the Philadelphia chromosome into therapy for CML

Druker, B. J. (2008) · Blood · doi:10.1182/blood-2008-07-077958 · Cited by 665 · see citing works

Recurrent gene fusions in prostate cancer

Kumar‐Sinha, C., Tomlins, S. A., & Chinnaiyan, A. M. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2402 · Cited by 663 · see citing works

Acute leukaemia in bcr/abl transgenic mice

Heisterkamp, N., Jenster, G. W., ten Hoeve, J., Zovich, D., Pattengale, P. K., & Groffen, J. (1990) · Nature · doi:10.1038/344251a0 · Cited by 660 · see citing works

Clonal origin of human tumors

Fialkow, P. J. (1976) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(76)90003-2 · Cited by 649 · see citing works

The origin of human cancers

Cairns, J. (1981) · Nature · doi:10.1038/289353a0 · Cited by 643 · see citing works

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

Copland, M., Hamilton, A., Elrick, L. J., Baird, J. W., Allan, E. K., Jordanides, N., Barow, M., Mountford, J. C., & Holyoake, T. L. (2006) · Blood · doi:10.1182/blood-2005-07-2947 · Cited by 635 · see citing works

Chronic myeloid leukaemia as a model of disease evolution in human cancer

Melo, J. V., & Barnes, D. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2147 · Cited by 616 · see citing works

The biology of CML blast crisis

Calabretta, B., & Perrotti, D. (2004) · Blood · doi:10.1182/blood-2003-12-4111 · Cited by 591 · see citing works

Chromosome Aberrations and Cancer

Solomon, E., Borrow, J., & Goddard, A. D. (1991) · Science · doi:10.1126/science.1957167 · Cited by 580 · see citing works

ErbB receptors: from oncogenes to targeted cancer therapies

Zhang, H., Berezov, A., Wang, Q., Zhang, G., Drebin, J. A., Murali, R., & Greene, M. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32278 · Cited by 573 · see citing works

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.

Daley, G. Q., & Baltimore, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9312 · Cited by 563 · see citing works

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

Bhatia, R., Holtz, M. S., Niu, N., Gray, R., Snyder, D., Sawyers, C. L., Arber, D. A., Slovak, M. L., & Forman, S. J. (2003) · Blood · doi:10.1182/blood-2002-09-2780 · Cited by 543 · see citing works

PML targeting eradicates quiescent leukaemia-initiating cells

Ito, K., Bernardi, R., Morotti, A., Matsuoka, S., Saglio, G. N., Ikeda, Y., Rosenblatt, J. M., Avigan, D., Teruya‐Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07016 · Cited by 538 · see citing works

Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells

Kuntz, E. M., Baquero, P., Michie, A. M., Dunn, K. M., Tardito, S., Holyoake, T. L., Helgason, G. V., & Gottlieb, E. (2017) · Nature Medicine · doi:10.1038/nm.4399 · Cited by 533 · see citing works

A historical overview of protein kinases and their targeted small molecule inhibitors

Roskoski, R. J. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.010 · Cited by 527 · see citing works

Smart drugs: Tyrosine kinase inhibitors in cancer therapy

Shawver, L. K., Slamon, D. J., & Ullrich, A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00039-9 · Cited by 524 · see citing works

The discovery of first-in-class drugs: origins and evolution

Eder, J., Sedrani, R., & Wiesmann, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4336 · Cited by 514 · see citing works

Clonal genomic alterations in glioma malignancy stages.

Cd, J., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjöld, M., Collins, V. P., & Cavenee, W. K. (1988) · PubMed · Cited by 512 · see citing works

Isolation of a Highly Quiescent Subpopulation of Primitive Leukemic Cells in Chronic Myeloid Leukemia

Holyoake, T. L., Jiang, X., Eaves, C. J., & Eaves, A. C. (1999) · Blood · doi:10.1182/blood.v94.6.2056 · Cited by 511 · see citing works

Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia

Bedi, A., Zehnbauer, B., Barber, J. P., Sharkis, S. J., & Jones, R. (1994) · Blood · doi:10.1182/blood.v83.8.2038.2038 · Cited by 506 · see citing works

CTCF and Cohesin in Genome Folding and Transcriptional Gene Regulation

Merkenschlager, M., & Nora, E. P. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083115-022339 · Cited by 505 · see citing works

A continuum model for tumour suppression

Berger, A. H., Knudson, A. G., & Pandolfi, P. P. (2011) · Nature · doi:10.1038/nature10275 · Cited by 503 · see citing works

Clinical pharmacokinetics of tyrosine kinase inhibitors

van Erp, N. P., Gelderblom, H., & Guchelaar, H.-J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.08.004 · Cited by 503 · see citing works

A robustness-based approach to systems-oriented drug design

Kitano, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2195 · Cited by 488 · see citing works

Response and Resistance to BCR-ABL1-Targeted Therapies

Braun, T. P., Eide, C. A., & Druker, B. J. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.006 · Cited by 488 · see citing works

The mutation spectrum revealed by paired genome sequences from a lung cancer patient

Lee, W., Jiang, Z., Liu, J., Haverty, P. M., Guan, Y., Stinson, J., Yue, P., Zhang, Y., Pant, K. P., Bhatt, D., et al. (2010) · Nature · doi:10.1038/nature09004 · Cited by 486 · see citing works

Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals

Biernaux, C., Loos, M., Sels, A., Huez, G., & Stryckmans, P. (1995) · Blood · doi:10.1182/blood.v86.8.3118.3118 · Cited by 485 · see citing works

Imatinib: A Breakthrough of Targeted Therapy in Cancer

Iqbal, N., & Iqbal, N. (2014) · Chemotherapy Research and Practice · doi:10.1155/2014/357027 · Cited by 481 · see citing works

Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.

Carlesso, N., Frank, D. A., & Griffin, J. D. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.811 · Cited by 481 · see citing works

A General Theory of Carcinogenesis

Comings, D. E. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.12.3324 · Cited by 462 · see citing works

The new cytogenetics: blurring the boundaries with molecular biology

Speicher, M. R., & Carter, N. P. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1692 · Cited by 460 · see citing works

Chronic Myelogenous Leukemia: Biology and Therapy

Faderl, S. H., Talpaz, M., Estrov, Z. E., & Kantarjian, H. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00008 · Cited by 457 · see citing works

Integrative detection and analysis of structural variation in cancer genomes

Dixon, J. R., Xu, J., Dileep, V., Zhan, Y., Song, F., Le, V. T., Yardımcı, G. G., Chakraborty, A., Bann, D. V., Wang, Y., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0195-8 · Cited by 452 · see citing works

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene

Shtivelman, E., Lifshitz, B., Gale, R. P., Roe, B. A., & Canaani, E. (1986) · Cell · doi:10.1016/0092-8674(86)90450-2 · Cited by 452 · see citing works

Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia

Johansson, B., Fioretos, T., & Mitelman, F. (2002) · Acta Haematologica · doi:10.1159/000046636 · Cited by 450 · see citing works

Chronic myelogenous leukemia: a concise update

Kantarjian, H. M., Deisseroth, A. B., Kurzrock, R., Estrov, Z. E., & Talpaz, M. (1993) · Blood · doi:10.1182/blood.v82.3.691.691 · Cited by 443 · see citing works

Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy

JENNINGS, C. D., & Foon, K. A. (1997) · Blood · doi:10.1182/blood.v90.8.2863 · Cited by 440 · see citing works

Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring

Jabbour, E. J., & Kantarjian, H. M. (2020) · American Journal of Hematology · doi:10.1002/ajh.25792 · Cited by 424 · see citing works

Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring

Jabbour, E. J., & Kantarjian, H. M. (2018) · American Journal of Hematology · doi:10.1002/ajh.25011 · Cited by 421 · see citing works

The BCR-ABL Story: Bench to Bedside and Back

Wong, S., & Witte, O. N. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104753 · Cited by 402 · see citing works

Polypeptide Growth Factors: Roles In Normal And Abnormal Cell Growth

Deuel, T. F. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.002303 · Cited by 395 · see citing works

THE CRITICAL ROLE OF CHROMOSOME TRANSLOCATIONS IN HUMAN LEUKEMIAS

Rowley, J. D. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.495 · Cited by 392 · see citing works

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

Preudhomme, C., Guilhot, J., Nicolini, F. E., Guerci‐Bresler, A., Huguet, F., Maloisel, F., Coiteux, V., Gardembas, M., Berthou, C., Vekhoff, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1004095 · Cited by 389 · see citing works

Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease

Jaiswal, S., & Libby, P. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0247-5 · Cited by 386 · see citing works

Massively Parallel Sequencing: The Next Big Thing in Genetic Medicine

Tucker, T., Marra, M. A., & Friedman, J. M. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.06.022 · Cited by 384 · see citing works

Chronic myeloid leukaemia

Apperley, J. F. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62120-0 · Cited by 383 · see citing works

DNA Microarrays in Clinical Oncology

Ramaswamy, S., & Golub, T. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.7.1932 · Cited by 379 · see citing works

Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia

Hermans, A., Heisterkamp, N., Lindern, M. V., van Baal, S., Meijer, D., van der Plas, D., Wiedemann, L. M., Groffen, J., Bootsma, D., & Grosveld, G. C. (1987) · Cell · doi:10.1016/0092-8674(87)90007-9 · Cited by 378 · see citing works

Imatinib as a Paradigm of Targeted Therapies

Druker, B. J. (2004) · Advances in cancer research · doi:10.1016/s0065-230x(04)91001-9 · Cited by 368 · see citing works

Detection of bcr - abl Fusion in Chronic Myelogeneous Leukemia by in Situ Hybridization

Tkachuk, D., Westbrook, C. A., Andreeff, M., Donlon, T. A., Cleary, M. L., Suryanarayan, K., Homge, M., Redner, A., Gray, J. W., & Pinkel, D. (1990) · Science · doi:10.1126/science.2237408 · Cited by 368 · see citing works

Identification of chromosome anomalies in the blastic phase of chronic myelocytic leukemia (CML) by Giemsa- and quinacrine-banding techniques

Hossfeld, D. K. (1974) · Human Genetics · doi:10.1007/bf00282208 · Cited by 26 · see citing works

"Masked" Ph1 chromosome abnormalities in CML: a report of two unique cases

Bernstein, R., Pinto, M., Rosendorff, J., Kramer, S., & Mendelow, B. (1984) · Blood · doi:10.1182/blood.v63.2.399.399 · Cited by 12 · see citing works

A Unique, Complex Variant Philadelphia Chromosome Translocation in a Patient With Typical Chronic Myelogenous Leukemia

Oudat, R., Khan, Z., & Glassman, A. B. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0437-aucvpc · Cited by 8 · see citing works

Chromosome band analysis in 19 cases of chronic myeloid leukemia: 9 chronic, 10 blastic, two with Ph1 (22q-) translocation on 17 short arm.

Engel, E., Bj, M., Flexner, J. M., & Krantz, S. B. (1975) · PubMed · Cited by 13 · see citing works

Absence of the 9q+chromosome in Ph1 negative chronic myelogenous leukaemia

Rowley, J. D. (1974) · Journal of Medical Genetics · doi:10.1136/jmg.11.2.166 · Cited by 15 · see citing works